Publications
2019
Genome-scale CRISPR screens are efficient in non-homologous end-joining deficient cells.
Ferreira da Silva J,
Salic S,
Wiedner M,
Datlinger P,
Essletzbichler P,
Hanzl A,
Superti-Furga G,
Bock C,
Winter G,
Loizou JI.
Sci Rep. 2019 Oct 31;9(1):15751. doi: 10.1038/s41598-019-52078-9.
2019
Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress.
Conde CD,
Petronczki ÖY,
Baris S,
Willmann KL,
Girardi E,
Salzer E,
Weitzer S,
Ardy RC,
Krolo A,
Ijspeert H,
Kiykim A,
Karakoc-Aydiner E,
Förster-Waldl E,
Kager L,
Pickl WF,
Superti-Furga G,
Martínez J,
Loizou JI,
Ozen A,
van der Burg M,
Boztug K.
J Clin Invest. 2019 Oct 1;129(10):4194-4206. doi: 10.1172/JCI128903.
2019
Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis.
Bösl K,
Ianevski A,
Than TT,
Andersen PI,
Kuivanen S,
Teppor M,
Zusinaite E,
Dumpis U,
Vitkauskiene A,
Cox RJ,
Kallio-Kokko H,
Bergqvist A,
Tenson T,
Merits A,
Oksenych V,
Bjørås M,
Anthonsen MW,
Shum D,
Kaarbø M,
Vapalahti O,
Windisch MP,
Superti-Furga G,
Snijder B,
Kainov D,
Kandasamy RK.
Front Immunol. 2019 Oct 4;10:2186. doi: 10.3389/fimmu.2019.02186.
2019
Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking.
Fauster A,
Rebsamen M,
Willmann KL,
César-Razquin A,
Girardi E,
Bigenzahn JW,Schischlik F,
Scorzoni S,
Bruckner M,
Konecka J,
Hörmann K,
Heinz LX,
Boztug K,Superti-Furga G.
Cell Death Differ. 2019Jun;26(6):1138-1155. doi: 10.1038/s41418-018-0192-6. Epub 2018 Sep 20.
2019
The Airn lncRNA does not require any DNAelements within its locus to silence distant imprinted genes.
Andergassen D,
Muckenhuber M,
Bammer PC,
Kulinski TM,
Theussl HC,
Shimizu T,Penninger JM,
Pauler FM,
Hudson QJ.
PLoS Genet. 2019Jul 22;15(7):e1008268. doi: 10.1371/journal.pgen.1008268. [Epub ahead of print]
2018
NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3.
Wuerth JD,
Habjan M,
Wulle J,
Superti-Furga G,
Pichlmair A,
Weber F.
J Virol. 2018 Nov 12;92(23). pii: e01202-18. doi: 10.1128/JVI.01202-18. Print 2018 Dec 1.
2018
Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.
Tsafou K,
Katschnig AM,
Radic-Sarikas B,
Mutz CN,
Iljin K,
Schwentner R,
Kauer MO,
Mühlbacher K,
Aryee DNT,
Westergaard D,
Haapa-Paananen S,
Fey V,
Superti-Furga G,
Toretsky J,
Brunak S,
Kovar H.
Oncotarget. 2018 Jul 24;9(57):31018-31031. doi: 10.18632/oncotarget.25760. eCollection 2018 Jul 24.
2018
SETD2 in MLL-rearranged leukemia - a complex case.
Skucha A,
Ebner J,
Grebien F.
Mol Cell Oncol. 2018 Aug 13;5(4):e1503492. doi: 10.1080/23723556.2018.1503492. eCollection 2018.
2018
Recent advances in combinatorial drug screening and synergy scoring.
Pemovska T,
Bigenzahn JW,
Superti-Furga G.
Curr Opin Pharmacol. 2018 Oct;42:102-110. doi: 10.1016/j.coph.2018.07.008. Epub 2018 Sep 5. Review.
2018
Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking.
Fauster A,
Rebsamen M,
Willmann KL,
César-Razquin A,
Girardi E,
Bigenzahn JW,
Schischlik F,
Scorzoni S,
Bruckner M,
Konecka J,
Hörmann K,
Heinz LX,
Boztug K,
Superti-Furga G.
Cell Death Differ. 2018 Sep 20. doi: 10.1038/s41418-018-0192-6. [Epub ahead of print]
